Shanghai Pharma Manufacturing Halves In April
US Congress Questions China-Only Clinical Data Quality
Executive Summary
China's main pharma hub of Shanghai reported sector output has plunged by more than half due in large part to the prolonged lockdown, while 58% of surveyed foreign companies in China across all industries project declining revenue.